Trevi Therapeutics, Inc. (TRVI)
16.61
-0.21
(-1.25%)
USD |
NASDAQ |
Sep 09, 15:01
Trevi Therapeutics Price to Book Value : 7.358 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 7.451 |
| September 04, 2026 | 7.646 |
| September 03, 2026 | 7.557 |
| September 02, 2026 | 7.553 |
| September 01, 2026 | 7.340 |
| August 31, 2026 | 7.354 |
| August 28, 2026 | 7.438 |
| August 27, 2026 | 7.956 |
| August 26, 2026 | 7.938 |
| August 25, 2026 | 7.952 |
| August 24, 2026 | 8.009 |
| August 21, 2026 | 7.956 |
| August 20, 2026 | 8.084 |
| August 19, 2026 | 8.332 |
| August 18, 2026 | 8.346 |
| August 17, 2026 | 8.186 |
| August 14, 2026 | 8.177 |
| August 13, 2026 | 8.040 |
| August 12, 2026 | 7.854 |
| August 11, 2026 | 7.885 |
| August 10, 2026 | 7.885 |
| August 07, 2026 | 8.200 |
| August 06, 2026 | 8.195 |
| August 05, 2026 | 8.262 |
| August 04, 2026 | 8.306 |
| Date | Value |
|---|---|
| August 03, 2026 | 7.929 |
| July 31, 2026 | 8.084 |
| July 30, 2026 | 8.151 |
| July 29, 2026 | 8.014 |
| July 28, 2026 | 8.164 |
| July 27, 2026 | 8.027 |
| July 24, 2026 | 7.768 |
| July 23, 2026 | 7.610 |
| July 22, 2026 | 7.690 |
| July 21, 2026 | 8.053 |
| July 20, 2026 | 7.429 |
| July 17, 2026 | 8.448 |
| July 16, 2026 | 7.690 |
| July 15, 2026 | 8.038 |
| July 14, 2026 | 7.934 |
| July 13, 2026 | 7.318 |
| July 10, 2026 | 7.903 |
| July 09, 2026 | 8.151 |
| July 08, 2026 | 8.235 |
| July 07, 2026 | 8.638 |
| July 06, 2026 | 7.952 |
| July 02, 2026 | 7.943 |
| July 01, 2026 | 7.801 |
| June 30, 2026 | 8.262 |
| June 29, 2026 | 13.90 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.699 |
| Corcept Therapeutics, Inc. | 17.62 |
| Veru, Inc. | 1.526 |
| Johnson & Johnson | 7.609 |
| Eli Lilly & Co. | 31.25 |
Price to Book Value Related Metrics
| Price | 16.61 |
| Earnings Yield | -2.06% |
| Market Cap | 2.366B |